RxDoctor Payments DataLook up a doctor →

Edward Fox

Round Rock, TXNPI 1871528042

Payments from drug & device makers

$6,766,199in general payments, 2019–2025

Across 1,191 payments — averaging $5681.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$4.1M
  • Biogen$521K
  • F. Hoffmann-la Roche AG$370K
  • Genentech, Inc.$350K
  • AbbVie$274K
  • Bristol Myers Squibb$211K
  • plus $896K from 47 others
$37,194in research payments, 2019–2025

Across 30 payments — averaging $1239.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • TG Therapeutics, Inc.$16K
  • F. Hoffmann-la Roche AG$10K
  • Hoffmann-la Roche Limited$5K
  • Novartis$5K
  • Sanofi$750
  • Novartis Pharma AG$704
  • plus $442 from 1 others

What the payments were for

  • Consulting fees$119,80323%
  • Speaking & faculty fees$331,87964%
  • Travel & lodging$28,5796%
  • Food & beverage$18,9284%
  • Education$17,6423%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis81$4,144,613
Biogen114$521,466
F. Hoffmann-la Roche AG51$369,892
Genentech, Inc.35$349,796
AbbVie(2 entities)52$273,636
Bristol Myers Squibb81$211,088
Sanofi50$199,362
Roche Products Limited13$128,880
Chugai Pharmaceutical Co., Ltd.27$105,778
Adamas Pharmaceuticals, Inc.33$99,030
EMD Serono, Inc.116$65,410
E.r. Squibb & Sons, L.L.C.38$60,492
Genentech USA, Inc.109$52,440
AstraZeneca51$38,846
Hoffmann-la Roche Limited3$30,609
Amgen(2 entities)67$29,570
TG Therapeutics, Inc.35$27,070
Jazz Pharmaceuticals Inc.11$22,650
Sanofi US Services Inc.1$13,726
Greenwich Biosciences, Inc.8$6,425
Novartis Pharma AG2$4,514
Teva Pharmaceuticals USA, Inc.24$4,355
Johnson & Johnson6$2,913
UCB, Inc.37$726
Daiichi Sankyo Inc.5$348
Acadia Pharmaceuticals Inc17$276
Neurocrine Biosciences, Inc.11$190
Lundbeck LLC9$175
Lilly USA, LLC10$155
Upsher-smith Laboratories LLC7$148
Pfizer18$147
Acorda Therapeutics, Inc6$122
Merz North America, Inc.1$121
Biohaven Pharmaceuticals, Inc.8$118
Tanabe Pharma America, Inc.6$116
Currax Pharmaceuticals LLC6$97
SK Life Science, Inc.4$97
Avanir Pharmaceuticals, Inc.7$96
Mallinckrodt Enterprises LLC3$92
Medtronic1$84
Sanofi-aventis U.S. LLC3$72
Kyowa Kirin, Inc.3$66
Argenx US, Inc.3$65
Biohaven Pharmaceutical Holding Company Ltd.3$62
Octapharma USA, Inc.3$53
Grifols USA, LLC2$41
Abbott2$37
MDD US Operations, LLC2$32
Amylyx Pharmaceuticals, Inc.1$25
Sumitomo Pharma America, Inc.1$24
Arbor Pharmaceuticals, Inc.2$22
Alkermes, Inc.1$21
Assertio Therapeutics, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Avonex Pen (4 Pack)Interferon Beta-1a16$153,487
Plegridy PenPeginterferon Beta-1a11$90,924
Glatiramer Acetate16$43,918
Teriflunomide13$6,369
Baclofen71$2,660
Dimethyl Fumarate15$1,687
Gabapentin54$1,498
Carbamazepine14$1,190
Tizanidine Hcl35$749
Duloxetine Hcl22$577
Levetiracetam12$532
Sertraline Hcl17$101
Escitalopram Oxalate13$82

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →